Ependymoma

Critical Reviews in Oncology/Hematology

Volumn 63, Issue 1, 2007, Pages 81-89

  Reni, Michele ^a   Gatta, Gemma ^b   Mazza, Elena ^a   Vecht, Charles ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Neurology Medical Center   (Netherlands)

Author keywords

Ependymomas; Prognosis; Treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; NITROSOUREA; PACLITAXEL; PLATINUM; PROCARBAZINE; TEMOZOLOMIDE; TOPOTECAN; VINCRISTINE;

BIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFICACY; EPENDYMOMA; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; NEUROECTODERM TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SUBEPENDYMOMA; TUMOR RECURRENCE;

AGE DISTRIBUTION; BRAIN NEOPLASMS; EPENDYMOMA; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INCIDENCE; INFRATENTORIAL NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SEX FACTORS; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34249311059     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.03.004     Document Type: Review

References (100)

1. Oppenheim J.S., Strauss R.C., Mormino J., et al. Ependymomas of the third ventricle. Neurosurgery 34 (1994) 350-352
2. Centeno R.S., Lee A.A., Winter J., and Barba D. Supratentorial ependymomas. Neuroimaging and clinicopathological correlation. J Neurosurg 64 (1986) 209-215
3. ENCR. European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.2 (1999). Lyon; 2001.
4. Parkin DM, Kramarova E, Draper JG, et al. International incidence of childhood cancer, vol. II. Lyon: IARC Scientific Pub. No. 144; 1998.
5. Berrino F, Capocaccia R, Coleman MP, et al. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003; 14 Suppl 5.
6. Gatta G., Corazziari I., Magnani C., et al. Childhood cancer survival in Europe. Ann Oncol 14 Suppl 5 (2003) v119-v127
7. Bergsagel D.J., Finegold M.J., Butel J.S., et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326 (1992) 988-993
8. Lednicky J.A., Garcea R.L., Bergsagel D.J., and Butel J.S. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212 (1995) 710-717
9. Engels E.A., Katki H.A., Nielsen N.M., et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 95 (2003) 532-539
10. Strickler H.D., Rosenberg P.S., Devesa S.S., et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 279 (1998) 292-295
11. Preston-Martin S., and Mack S. Neoplasms of the nervous system. In: Schottenfeld D., and Fraumeni J.F. (Eds). Cancer epidemiology and prevention (1996), Oxford University Press, New York 1213-1281
12. Little J. Epidemiology of childhood cancer. Lyon: IARC Scient. Publ No. 149; 1999.
13. Bunin G.R., Kuijten R.R., Buckley J.D., et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 329 (1993) 536-541
14. Wiestler OD, Schiffer D, Coons SW, et al. Ependymal tumours. In: Kleihues P, Cavenee WC, editors. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Nervous System, 2000, p. 71-81.
15. Schiffer D., and Giordana M.T. Prognosis of ependymoma. Childs Nerv Syst 14 (1998) 357-361
16. Kimura T., Budka H., and Soler-Federsppiel S. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors. Clin Neuropathol 5 (1986) 21-27
17. Tabuchi K., Moriya Y., Furuta T., et al. S-100 protein in human glial tumours. Qualitative and quantitative studies. Acta Neurochir (Wien) 65 (1982) 239-251
18. Mannoji H., and Becker L.E. Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression. Cancer 61 (1988) 1377-1385
19. Lamszus K., Lachenmayer L., Heinemann U., et al. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 91 (2001) 803-808
20. Weremowicz S., Kupsky W.J., Morton C.C., and Fletcher J.A. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 61 (1992) 193-196
21. Nijssen P.C., Deprez R.H., Tijssen C.C., et al. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neurosurg Psychiatry 57 (1994) 1245-1248
22. Ward S., Harding B., Wilkins P., et al. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32 (2001) 59-66
23. Sato K., Schauble B., Kleihues P., and Ohgaki H. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int J Cancer 66 (1996) 305-308
24. Bijlsma E.K., Voesten A.M., Bijleveld E.H., et al. Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer 13 (1995) 272-277
25. Applegate G.L., and Marymont M.H. Intracranial ependymomas: a review. Cancer Invest 16 (1998) 588-593
26. Metzger A.K., Sheffield V.C., Duyk G., et al. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 88 (1991) 7825-7829
27. Suzuki S.O., and Iwaki T. Amplification and overexpression of mdm2 gene in ependymomas. Mod Pathol 13 (2000) 548-553
28. Birch B.D., Johnson J.P., Parsa A., et al. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39 (1996) 135-140
29. von Haken M.S., White E.C., Daneshvar-Shyesther L., et al. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17 (1996) 37-44
30. Ebert C., von Haken M., Meyer-Puttlitz B., et al. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155 (1999) 627-632
31. Rousseau-Merck M., Versteege I., Zattara-Cannoni H., et al. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas. Cancer Genet Cytogenet 121 (2000) 223-227
32. Hirose Y., Aldape K., Bollen A., et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158 (2001) 1137-1143
33. McLaughlin M.P., Marcus Jr. R.B., Buatti J.M., et al. Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 40 (1998) 845-850
34. Schild S.E., Nisi K., Scheithauer B.W., et al. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 42 (1998) 953-958
35. Vanuytsel L., and Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys 21 (1991) 825-830
36. In: Hermanenk P., and Sobin L.H. (Eds). TNM classification of malignant tumours. 4th ed. (1987), Springer-Verlag, Heidelberg 226
37. Salazar O.M. A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas. Int J Radiat Oncol Biol Phys 9 (1983) 1231-1234
38. Lyons M.K., and Kelly P.J. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28 (1991) 659-664
39. Stuben G., Stuschke M., Kroll M., et al. Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol 45 (1997) 3-10
40. Schiffer D., Chio A., Giordana M.T., et al. Histologic prognostic factors in ependymoma. Childs Nerv Syst 7 (1991) 177-182
41. Prayson R.A. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Mod Pathol 10 (1997) 304-310
42. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 5 (1992) 924-931
43. Schiffer D., Chio A., Cravioto H., et al. Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 29 (1991) 206-210
44. Robertson P.L., Zeltzer P.M., Boyett J.M., et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88 (1998) 695-703
45. Nazar G.B., Hoffman H.J., Becker L.E., et al. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72 (1990) 408-417
46. Garrett P.G., and Simpson W.J. Ependymomas: results of radiation treatment. Int J Radiat Oncol Biol Phys 9 (1983) 1121-1124
47. Di Marco A., Campostrini F., Pradella R., et al. Postoperative irradiation of brain ependymomas. Analysis of 33 cases. Acta Oncol 27 (1988) 261-267
48. Ernestus R.I., Schroder R., Stutzer H., and Klug N. The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg 11 (1997) 421-428
49. Shaw E.G., Evans R.G., Scheithauer B.W., et al. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13 (1987) 1457-1462
50. West C.R., Bruce D.A., Duffner P.K., and Ependymomas. Factors in clinical and diagnostic staging. Cancer 56 (1985) 1812-1816
51. Ross G.W., and Rubinstein L.J. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70 (1989) 31-36
52. Spagnoli D., Tomei G., Ceccarelli G., et al. Combined treatment of fourth ventricle ependymomas: report of 26 cases. Surg Neurol 54 (2000) 19-26
53. Pierre-Kahn A., Hirsch J.F., Roux F.X., et al. Intracranial ependymomas in childhood. Survival and functional results of 47 cases. Childs Brain 10 (1983) 145-156
54. Kovalic J.J., Flaris N., Grigsby P.W., et al. Intracranial ependymoma long term outcome, patterns of failure. J Neurooncol 15 (1993) 125-131
55. Vanuytsel L.J., Bessell E.M., Ashley S.E., et al. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 23 (1992) 313-319
56. Wallner K.E., Wara W.M., Sheline G.E., and Davis R.L. Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1937-1941
57. Paulino A.C., and Wen B.C. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys 47 (2000) 585-589
58. Korshunov A., Golanov A., and Timirgaz V. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. J Neurol Sci 177 (2000) 72-82
59. Merchant T.E., Haida T., Wang M.H., et al. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 86 (1997) 943-949
60. Zulch K.J. Brain tumours: their biology and pathology. 3rd ed. (1986), Springer-Verlag, New York p. 258-76
61. Goldwein J.W., Leahy J.M., Packer R.J., et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 19 (1990) 1497-1502
62. Isaacson S.R. Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol 47 (2000) 231-238
63. Rousseau P., Habrand J.L., Sarrazin D., et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 28 (1994) 381-386
64. Jenkin D. Posterior fossa tumors in childhood: radiation treatment. Clin Neurosurg 30 (1983) 203-208
65. Healey E.A., Barnes P.D., Kupsky W.J., et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28 (1991) 666-671
66. Hukin J., Epstein F., Lefton D., and Allen J. Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 29 (1998) 40-45
67. Imhof H.G., Hany M., Wiestler O.D., and Glanzmann C. Long-term follow-up in 39 patients with an ependymoma after surgery and irradiation. Strahlenther Onkol 168 (1992) 513-519
68. Waldron J.N., Laperriere N.J., Jaakkimainen L., et al. Spinal cord ependymomas: a retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys 27 (1993) 223-229
69. Clover L.L., Hazuka M.B., and Kinzie J.J. Spinal cord ependymomas treated with surgery and radiation therapy. A review of 11 cases. Am J Clin Oncol 16 (1993) 350-353
70. Schwartz T.H., and McCormick P.C. Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol 47 (2000) 211-218
71. Mork S.J., and Loken A.C. Ependymoma: a follow-up study of 101 cases. Cancer 40 (1977) 907-915
72. Perilongo G., Massimino M., Sotti G., et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 29 (1997) 79-85
73. Paulino A.C. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?. Int J Radiat Oncol Biol Phys 49 (2001) 757-761
74. Donahue B., and Steinfeld A. Intracranial ependymoma in the adult patient: successful treatment with surgery and radiotherapy. J Neurooncol 37 (1998) 131-133
75. Palma L., Celli P., Mariottini A., et al. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst 16 (2000) 170-175
76. Davis C., and Symon L. Posterior fossa ependymomas in adults. Acta Neurochir (Wien) 82 (1986) 115-117
77. Karim A.B., Afra D., Cornu P., et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52 (2002) 316-324
78. Ernestus R.I., and Wilcke O. Spinal metastases of intracranial ependymomas. Four case reports and review of the literature. Neurosurg Rev 13 (1990) 147-154
79. Packer R.J., Schut L., and Siegel K.R. Dissemination of primary central nervous system tumors of childhood: incidence and clinical implications. Prog Exp Tumor Res 30 (1987) 206-214
80. Marks J.E., and Adler S.J. A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys 8 (1982) 37-43
81. Salazar O.M., Castro-Vita H., VanHoutte P., et al. Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 59 (1983) 652-659
82. Kim Y.H., and Fayos J.V. Intracranial ependymomas. Radiology 124 (1977) 805-808
83. Merchant T.E., Zhu Y., Thompson S.J., et al. Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. Int J Radiat Oncol Biol Phys 52 (2002) 325-332
84. Evans A.E., Anderson J.R., Lefkowitz-Boudreaux I.B., and Finlay J.L. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol 27 (1996) 8-14
85. Bouffet E., and Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv Syst 15 (1999) 563-570
86. Duffner P.K., Horowitz M.E., Krischer J.P., et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328 (1993) 1725-1731
87. Kuhl J., Muller H.L., Berthold F., et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr 210 (1998) 227-233
88. Mason W.P., Goldman S., Yates A.J., et al. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma-a report of the Children's Cancer Group. J Neurooncol 37 (1998) 135-143
89. Grill J., Kalifa C., Doz F., et al. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 25 (1996) 7-12
90. Aggarwal R., Yeung D., Kumar P., et al. Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. Radiother Oncol 43 (1997) 269-273
91. Stafford S.L., Pollock B.E., Foote R.L., et al. Stereotactic radiosurgery for recurrent ependymoma. Cancer 88 (2000) 870-875
92. Jawahar A., Kondziolka D., Flickinger J.C., and Lunsford L.D. Adjuvant stereotactic radiosurgery for anaplastic ependymoma. Stereotact Funct Neurosurg 73 (1999) 23-30
93. Kadota R.P., Stewart C.F., Horn M., et al. Topotecan for the treatment of recurrent or progressive central nervous system tumors-a pediatric oncology group phase II study. J Neurooncol 43 (1999) 43-47
94. Ruda R., Costanza A., Nobile M., et al. Response of ependymomas to chemotherapy with temozolomide. J Neurooncol 3 (2001) 66
95. Corn B.W., Yousem D.M., Scott C.B., et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 74 (1994) 2828-2835
96. Crossen J.R., Garwood D., Glatstein E., and Neuwelt E.A. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 (1994) 627-642
97. Kumar A.J., Leeds N.E., Fuller G.N., et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217 (2000) 377-384
98. Klein M., Heimans J.J., Aaronson N.K., et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360 (2002) 1361-1368
99. Gregor A., Cull A., Traynor E., et al. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 41 (1996) 55-59
100. Brandes A.A., Pasetto L.M., Lumachi F., and Monfardini S. Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management. J Neurooncol 47 (2000) 85-92